📊 This is a company profile preview from Tablestat.com Request a Free Trial Now

Company profile: Tris Pharma

1.1 - Company Overview

Tris Pharma Logo

Tris Pharma

Headquarter: United States
Founded: 20XX🔒
Employees: 100-500🔒

Company description

  • Provider of specialty generic pharmaceuticals leveraging its LiquiXR drug delivery technology for sustained-release formulations, including ADHD treatments with flexible dosing for patients aged 6+, a portfolio of 10 generic products with 20+ in development, technology licensing of its delivery technologies, and partnerships to enhance product development and commercialization.

Products and services

  • ADHD Products: LiquiXR-enabled therapies offering flexible dosing for patients aged 6 and older, providing sustained-release treatment options for ADHD
  • LiquiXR Drug Delivery Technology: Proprietary, sustained-release platform suitable for various formulations, including those aiding patients with ADHD, enabling sustained release of medication
  • Generics Portfolio: Specialty-focused, high-quality generics comprising 10 products with over 20 in development, offered as patient-friendly options

Key contacts

🔒
🔒

Financial details

🔒

1.2 - Competitors and similar companies to Tris Pharma

Atalanta Therapeutics Logo

Atalanta Therapeutics

HQ: United States Website
  • Description: Provider of biotechnology focused on pioneering new treatment options for neurodegenerative diseases.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Atalanta Therapeutics company profile →
ANS Medical Logo

ANS Medical

HQ: United States Website
  • Description: Provider of neuromodulation devices, engaged in their design, development, and manufacture.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full ANS Medical company profile →
CNS Therapeutics Logo

CNS Therapeutics

HQ: United States Website
  • Description: Provider of pharmaceuticals for site-specific delivery to the central nervous system to treat neurological disorders and chronic pain; develops and markets safe, high-quality pharmaceuticals, including its first FDA-approved product, Gablofen. Based in St. Paul, Minn.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full CNS Therapeutics company profile →
BlackThorn Therapeutics Logo

BlackThorn Therapeutics

HQ: United States Website
  • Description: Provider of clinical-stage neurobehavioral health, pioneering the next generation of artificial intelligence.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full BlackThorn Therapeutics company profile →
Inscopix Logo

Inscopix

HQ: United States Website
  • Description: Provider of neural activity imaging solutions for freely behaving subjects, enabling links between circuit dynamics and behavior. Offers the nVue dual-color system with expanded storage for longitudinal studies, the LScape module for wider field of view and longer working distance in cortical imaging, and Multicolor Data Processing software for streamlined miniscope analysis with PCA/ICA or CNMFe, filtering, and longitudinal registration.
  • Rationale: This competitor operates in a highly similar market segment with overlapping features.
  • Company type: Private company
  • Employees: ●●●●●
  • Total funding raised: $●●●m
  • Backers: ●●●●●●●●●●
  • Acquisitions: ●●
View full Inscopix company profile →
🔒

2.M&A buyers

2.1 Potential strategic acquirers in the sector

🔒
🔒
🔒
🔒 View all strategic buyers with complete profiles
Start Free Trial →

2.2 - Strategic buyer groups for Tris Pharma

🔒

Buyer group 1: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 2: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔒

Buyer group 3: ████████ ████████

●● companies
Description: ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████ ████████
Key Products: ████████, ████████, ████████, ████████
🔒 View all companies in this group
Request Free Trial Now →
🔓 Unlock all detailed buyer group breakdowns with complete company profiles
Start Free Trial →

3. Investors and private equity firms

3.1 - Buyout funds investing in similar companies to Tris Pharma

2.2 - Growth funds investing in similar companies to Tris Pharma

🔒 View all growth equity funds with complete profiles
Start Free Trial →

4 - Top valuation comps for Tris Pharma

4.2 - Public trading comparable groups for Tris Pharma

🔓 Unlock all public trading comparable groups with complete valuation data
Start Free Trial →

4.3 - M&A Transactions similar to Tris Pharma

Selected M&A transactions

Date Target Description Buyer(s) Relevance EV EV/Revenue EV/EBITDA
🔒 View all M&A transactions with complete deal terms
Request Free Trial Now →

Frequently Asked Questions

About Tris Pharma

What does Tris Pharma do?

Tris Pharma is a provider of specialty generic pharmaceuticals leveraging its LiquiXR drug delivery technology for sustained-release formulations, including ADHD treatments with flexible dosing for patients aged 6+, a portfolio of 10 generic products with 20+ in development, technology licensing of its delivery technologies, and partnerships to enhance product development and commercialization.

Who are Tris Pharma's competitors?

Tris Pharma's competitors and similar companies include Atalanta Therapeutics, ANS Medical, CNS Therapeutics, BlackThorn Therapeutics, and Inscopix.

Where is Tris Pharma headquartered?

Tris Pharma is headquartered in United States.

How many employees does Tris Pharma have?

Tris Pharma has 1,000 employees 🔒.

When was Tris Pharma founded?

Tris Pharma was founded in 2010 🔒.

What sector and industry vertical is Tris Pharma in?

Tris Pharma is in the Enterprise Software 🔒 sector and industry

M&A Buyers & Acquirers for Tris Pharma

Who are the top strategic acquirers in Tris Pharma's sector and industry

Top strategic M&A buyers and acquirers in Tris Pharma's sector include ████████, ██████████, ██████, ████████, and ██████████ 🔒.

Which M&A buyer groups are most relevant for Tris Pharma?

Top strategic M&A buyers groups and sectors for Tris Pharma include █████████████████ , ████████████████, █████████████, ████████████, and ████████████████ 🔒.

Financial Investors investing in Tris Pharma's sector and industry vertical

Which are the top PE firms investing in Tris Pharma's sector and industry vertical?

Top PE firms investing in Tris Pharma's sector and industry vertical include ████████, ██████████, ████████, and ██████████ 🔒.

Who are the top buyout funds acquiring in Tris Pharma's sector and industry vertical?

Active PE funds and buyout funds acquiring companies in Tris Pharma's sector and industry vertical include █████████, ██████████, ████████████, and ████████████ 🔒.

Who are the top growth equity funds investing in companies in Tris Pharma's sector and industry vertical?

Growth funds and venture capital funds investing in companies similar to Tris Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Valuation benchmarks of companies in Tris Pharma's sector and industry

Which are the key public companies that are relevant trading comps benchmarks for Tris Pharma?

The key public trading comparables and valuation benchmarks for Tris Pharma include █████████, ██████████, ████████████, and ████████████ 🔒.

Which are the key trading comparable groups for Tris Pharma for public valuation benchmarks?

Our platform tracks detailed public trading comparable groups and valuation benchmarks for Tris Pharma with complete valuation multiples, growth metrics, and profitability data. Access the full database to benchmark your company against relevant public comparables.

What are recent M&A transactions in Tris Pharma's sector and industry vertical?

Our platform tracks relevant M&A transactions comparables and valuation benchmarks for Tris Pharma with complete deal terms, valuation multiples, and strategic rationale. Access the full database to benchmark pricing and identify active acquirers.

What are recent capital raises and funding rounds in Tris Pharma's' sector and industry vertical?

Access recent funding rounds and capital raises in Tris Pharma's sector and industry vertical including growth equity, venture capital, and buyout investments. Our database includes round size, lead investors and valuations.

Ready to Find the Right Buyers?

Access complete buyer lists, valuation data, and M&A intelligence for Tris Pharma

Launch login modal Launch register modal